RE:RE:in at 2.05 No point in trying to time the market. Hoping to see this in the $5-7 range by the end of the year. If they can show year over year revenue growth I'm thinking it will pop like Xebec did. On the one hand if the share price can ride Xebec's coat tails that will be great, but by the same token I have some concern that if Xebec fails to deliver operationally in the next year that the market might also lose confidence in GRN. Have to keep an eye on both. I wasn't happy with the share dilution to fund growth with Xebec so I sold that for a huge win and added to my position in GRN. It's a buy and hold for me.